V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280011607 | 280008757 | 1.65 | null | null | 2014-06-03 | 2014-06-23 | Ifosfamide PVI 1g/m2 14day | N | N | 280025900 | IFOSFAMIDE |
| 280011608 | 280008781 | 0.84 | 90 | Palliative (P) | null | 2018-11-05 | STS Rhabdomyosarcoma RMS 2005 IVADo | N | null | 280026065 | RMS 2005 TRIAL |
| 280011609 | 280005318 | 0.9 | 72 | Palliative (P) | 2014-06-04 | 2014-07-31 | CETUXIMAB + RT | N | N | 280026223 | CETUXIMAB + RT |
| 280011610 | 280005341 | 1.95 | null | Curative (C) | 2015-05-25 | 2015-05-27 | Cisplatin | N | N | 280026309 | CISPLATIN |
| 280011611 | 280005345 | 1.7 | null | Neo-adjuvant (N) | 2018-01-17 | 2018-01-17 | Doxorubicin 75mg/m2 | 02 | N | 280026313 | DOXORUBICIN |
| 280011612 | 280005372 | 1.65 | 104.7 | Neo-adjuvant (N) | 2015-11-24 | 2015-12-07 | CETUXIMAB + RT | N | N | 280026402 | CETUXIMAB + RT |
| 280011613 | 280005389 | 1.72 | 70 | Curative (C) | 2017-05-02 | 2017-07-09 | Cisplatin 7 day | N | N | 280026547 | CISPLATIN |
| 280011614 | 280011307 | 1.79 | 94 | Neo-adjuvant (N) | null | 2016-08-16 | Cisplatin | N | N | 280026571 | CISPLATIN |
| 280011615 | 280005409 | 1.67 | 91.7 | Adjuvant (A) | 2015-10-24 | 2015-11-19 | CARBOPLATIN + RT | null | null | 280026700 | CARBOPLATIN + RT |
| 280011616 | 280008852 | 1.6 | 70.6 | Palliative (P) | null | 2015-02-27 | Cisplatin | N | Y | 280026704 | CISPLATIN |
| 280011617 | 280005419 | 1.68 | 92 | Curative (C) | 2018-01-10 | 2018-01-10 | Cetuximab + Radiotherapy Maint | N | Y | 280026722 | CETUXIMAB + RT |
| 280011618 | 280005421 | 1.56 | null | Neo-adjuvant (N) | 2015-10-09 | 2015-10-16 | Ifosfamide 3g/m2 5 day | 02 | null | 280026724 | IFOSFAMIDE |
| 280011619 | 280005438 | 1.65 | 61 | Palliative (P) | 2015-04-22 | 2015-04-28 | Paclitaxel 80mg/m2 day 1 8 15 | N | null | 280026803 | PACLITAXEL |
| 280011620 | 280012013 | 0 | null | Curative (C) | null | 2015-01-16 | STS Rhabdomyosarcoma RMS 2005 IVADo | N | N | 280026811 | RMS 2005 TRIAL |
| 280011621 | 280005452 | null | 60 | Palliative (P) | 2013-08-13 | 2013-08-13 | DOXORUBICIN | 02 | N | 280026839 | DOXORUBICIN |
| 280011622 | 280005454 | 1.8 | 64.9 | Neo-adjuvant (N) | 2016-04-03 | 2016-06-11 | Cisplatin | N | N | 280026865 | CISPLATIN |
| 280011623 | 280005464 | 1.66 | null | null | 2015-07-10 | 2015-07-12 | Ifosfamide | N | N | 280026900 | IFOSFAMIDE |
| 280011624 | 280008877 | 1.66 | 12.3 | null | null | 2014-06-05 | Ifosfamide | N | N | 280026902 | IFOSFAMIDE |
| 280011625 | 280005474 | 1.8 | 116 | Not known (9) | 2016-03-31 | 2016-05-21 | DOXORUBICIN | 01 | N | 280026919 | DOXORUBICIN |
| 280011626 | 280008883 | 0 | 0 | Palliative (P) | 2014-10-07 | 2014-10-07 | Ifosfamide PVI 1g/m2 14day | null | null | 280026932 | IFOSFAMIDE |
| 280011627 | 280005529 | 1.58 | 40.1 | Palliative (P) | 2017-01-20 | 2017-05-03 | DOXORUBICIN | N | N | 280027162 | DOXORUBICIN |
| 280011628 | 280005544 | 1.69 | 91.5 | Palliative (P) | 2016-05-12 | 2016-06-05 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | 280027206 | PACLITAXEL |
| 280011629 | 280005567 | 1.7 | 71.6 | Curative (C) | 2018-04-30 | 2018-05-21 | Ifosfamide | N | N | 280027352 | IFOSFAMIDE |
| 280011630 | 280008927 | null | null | Adjuvant (A) | null | 2015-07-26 | CARBOPLATIN + RT | N | N | 280027379 | CARBOPLATIN + RT |
| 280011631 | 280005580 | 0 | 65 | Disease modification (D) | 2016-05-24 | 2016-05-25 | STS Rhabdo RMS 2005 Vin Cyclo | null | null | 280027402 | RMS 2005 TRIAL |
| 280011632 | 280005605 | 1.76 | 66.8 | Palliative (P) | 2014-02-07 | 2014-02-12 | PACLITAXEL | 02 | null | 280027524 | PACLITAXEL |
| 280011633 | 280005607 | 1.58 | null | Not known (9) | 2016-02-17 | 2016-05-28 | STS Rhabdomyosarcoma RMS 2005 IVA | N | N | 280027534 | IVA |
| 280011634 | 280005615 | 1.56 | 52.4 | Palliative (P) | 2016-01-13 | 2016-01-16 | Ifosfamide | null | null | 280027543 | IFOSFAMIDE |
| 280011635 | 280005619 | 1.76 | 98 | Curative (C) | null | 2016-03-22 | CETUXIMAB + RT | N | N | 280027545 | CETUXIMAB + RT |
| 280011636 | 280010557 | 1.79 | 98 | Palliative (P) | 2017-05-02 | 2017-05-02 | Paclitaxel 80mg/m2 day 1 8 15 | null | null | 280027573 | PACLITAXEL |
| 280011637 | 280005638 | 1.73 | 72 | Palliative (P) | 2018-03-17 | 2018-03-17 | IVA | 2 | N | 280027609 | IVA |
| 280011638 | 280011339 | 1.75 | 65.9 | Palliative (P) | 2017-02-17 | 2017-07-13 | PACLITAXEL | N | N | 280027612 | PACLITAXEL |
| 280011639 | 280011724 | 1.64 | 14.45 | Palliative (P) | 2019-01-22 | 2019-04-01 | Paclitaxel 7 day | N | N | 280027660 | PACLITAXEL |
| 280011640 | 280005675 | 1.63 | 70.6 | Neo-adjuvant (N) | 2019-03-03 | 2019-04-02 | Ifosfamide | Y | N | 280027748 | IFOSFAMIDE |
| 280011641 | 280008978 | 0 | null | Neo-adjuvant (N) | 2018-11-10 | 2018-11-17 | STS Rhabdomyosarcoma RMS 2005 IVADo | 02 | N | 280027755 | RMS 2005 TRIAL |
| 280011642 | 280005688 | 1.8 | 84 | Palliative (P) | null | 2017-03-26 | Cetuximab + Radiotherapy Load | N | Y | 280027768 | CETUXIMAB + RT |
| 280011643 | 280005691 | 0 | null | Disease modification (D) | 2019-09-04 | 2019-09-04 | STS Rhabdo RMS 2005 2nd Topo Cyclo | null | Y | 280027776 | RMS 2005 TRIAL |
| 280011644 | 280005693 | 1.73 | null | Not known (9) | 2017-02-25 | 2017-03-03 | PACLITAXEL | 02 | N | 280027791 | PACLITAXEL |
| 280011645 | 280005695 | 0 | 120 | Palliative (P) | 2018-04-28 | 2018-04-29 | STS Rhabdo RMS 2005 Vin Cyclo | 02 | N | 280027801 | RMS 2005 TRIAL |
| 280011646 | 280008987 | 1.77 | 106 | null | 2014-02-19 | 2015-02-12 | Ifosfamide | 02 | N | 280027817 | IFOSFAMIDE |
| 280011647 | 280005703 | null | 60.1 | Curative (C) | 2017-02-24 | 2017-02-24 | STS Rhabdomyosarcoma RMS 2005 IVA | 2 | N | 280027820 | IVA |
| 280011648 | 280011344 | 1.14 | 67 | Curative (C) | 2019-01-20 | 2019-03-07 | STS Rhabdomyosarcoma RMS 2005 IVA | 02 | Y | 280027822 | IVA |
| 280011649 | 280005706 | 1.72 | 77.25 | Palliative (P) | null | 2017-01-21 | Cetuximab + Radiotherapy Load | N | N | 280027833 | CETUXIMAB + RT |
| 280011650 | 280005713 | 1.62 | 16 | Curative (C) | 2019-06-10 | 2019-06-11 | CARBOPLATIN + RT | null | Y | 280027853 | CARBOPLATIN + RT |
| 280011651 | 280005716 | null | 40.1 | Palliative (P) | 2016-02-06 | 2016-02-29 | Cisplatin | 02 | N | 280027858 | CISPLATIN |
| 280011652 | 280005730 | 1.65 | 74.3 | Palliative (P) | 2018-07-01 | 2018-08-12 | IRINOTECAN + TEMOZOLOMIDE | Y | N | 280027905 | IRINOTECAN + TEMOZOLOMIDE |
| 280011653 | 280005734 | 1.85 | 62 | Palliative (P) | null | 2016-10-10 | Doxorubicin + Ifosfamide | N | null | 280027914 | DOXORUBICIN + IFOSFAMIDE |
| 280011654 | 280005739 | 1.78 | 68 | Palliative (P) | null | 2013-06-14 | GEMCITABINE | N | null | 280027926 | GEMCITABINE |
| 280011655 | 280005748 | 1.6 | null | Neo-adjuvant (N) | 2013-09-16 | 2013-10-11 | EW EuroEwing 99 : VIDE | null | null | 280027971 | EURO-EWING |
| 280011656 | 280009017 | 1.64 | 66.5 | Curative (C) | 2016-05-10 | 2016-05-10 | Carboplatin + Etoposide iv&po | 2 | N | 280027992 | CARBOPLATIN + ETOPOSIDE |